246 related articles for article (PubMed ID: 9110288)
1. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of leukemia cutis.
Dorfman DM; Kraus M; Perez-Atayde AR; Barnhill RL; Pinkus GS; Granter SR
Mod Pathol; 1997 Apr; 10(4):283-8. PubMed ID: 9110288
[TBL] [Abstract][Full Text] [Related]
2. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
4. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
[TBL] [Abstract][Full Text] [Related]
6. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
Dworzak MN; Fröschl G; Printz D; Zen LD; Gaipa G; Ratei R; Basso G; Biondi A; Ludwig WD; Gadner H
Leukemia; 2004 Apr; 18(4):703-8. PubMed ID: 14961034
[TBL] [Abstract][Full Text] [Related]
7. Expression of JL1 is an effective adjunctive marker of leukemia cutis.
Park YS; Park SH; Park SJ; Kim Y; Jang KT; Ko YH; Lee MW; Huh JR; Park CS
Arch Pathol Lab Med; 2010 Jan; 134(1):95-102. PubMed ID: 20073611
[TBL] [Abstract][Full Text] [Related]
8. BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
Soslow RA; Zukerberg LR; Harris NL; Warnke RA
Mod Pathol; 1997 Aug; 10(8):810-7. PubMed ID: 9267824
[TBL] [Abstract][Full Text] [Related]
9. CD4 and CD8 double-negative adult T-cell leukemia/lymphoma with monomorphic cells expressing CD99: a diagnostic challenge in a country non-endemic for human T-cell leukemia virus.
Lin TH; Wu HC; Hsieh YC; Tseng CE; Ichinohasama R; Chuang SS
Pathol Int; 2013 Feb; 63(2):132-7. PubMed ID: 23464972
[TBL] [Abstract][Full Text] [Related]
10. Significance of CD99 expression in T-lineage acute lymphoblastic leukemia.
Enein AA; Rahman HA; Sharkawy NE; Elhamid SA; Abbas SM; Abdelfaatah R; Khalil M; Fathalla LA
Cancer Biomark; 2016 Mar; 17(2):117-23. PubMed ID: 27002769
[TBL] [Abstract][Full Text] [Related]
11. [Characteristic analysis of acute leukemia immunophenotyping in 180 cases by flow cytometry].
Yao ZJ; Liao L; Dang YH; Zhang J; Tian Y; Feng K; Qi CY; Wang JF; Chen H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):83-5. PubMed ID: 14989776
[TBL] [Abstract][Full Text] [Related]
12. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
Klobusická M; Babusíková O; Hrivnáková A
Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma.
Weidner N; Tjoe J
Am J Surg Pathol; 1994 May; 18(5):486-94. PubMed ID: 7513503
[TBL] [Abstract][Full Text] [Related]
17. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
18. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]